
Japanese Commercial Rocket Kairos Fails Third Launch Attempt
A Japanese commercial company experienced its third failed launch attempt for the 18-meter solid-fuel rocket Kairos, which was carrying five experimental satellites.
10 stories found

A Japanese commercial company experienced its third failed launch attempt for the 18-meter solid-fuel rocket Kairos, which was carrying five experimental satellites.
The private small rocket "Kairos No. 3", whose launch was postponed at the last minute on the 4th, is scheduled to be launched from a launch site in Wakayama Prefecture at 11:10 AM on the 5th.
The launch of the Kairos-3 small rocket, developed by a Tokyo-based venture company, has been rescheduled for March 4th at 11 AM from a launch site in Wakayama Prefecture. The original March 1st launch was postponed due to high winds.
The launch window for the unit, which will carry five satellites, runs until March 25.

Japan’s Space One said its Kairos rocket terminated its flight after lift-off on Thursday, failing to achieve the country’s first entirely commercial satellite launch on its third attempt in a row. Kairos “terminated the flight after judging that the achievement of its mission would be difficult”, the company said in a statement. “We are currently investigating the details.” Space One’s Kairos No 3, a 23-tonne solid-fuel rocket, lifted off in the morning from the privately run Space Port K...
The Kairos No. 3 small rocket, developed by a Tokyo-based venture company, is scheduled for launch on April 4th from Wakayama Prefecture. This third attempt follows two previous failures, and a successful orbital insertion would mark a first for a private company in Japan.
The launch of the Kairos-3 small rocket, developed by a Tokyo-based venture company, was scheduled for the morning of the 1st from a launch site in Wakayama Prefecture but was canceled due to weather conditions. A new launch date will be announced once decided.
The decision puts another dent in the firm’s bid to be the first private Japanese company to place satellites in orbit with a domestically developed rocket.
Kairos Pharma has signed a binding strategic asset acquisition for exclusive worldwide rights to CL-273 from Orbimed and Torrey Pines Investment-backed Celyn Therapeutics.
The rocket is set to lift off from the company’s Spaceport Kii launch site in the town of Kushimoto, Wakayama Prefecture, between around 11 a.m. and 11:20 a.m.